Cohance Lifesciences Limited — Others, 26-08-2025: Shareholders meeting

Cohance Lifesciences has announced its 7th Annual General Meeting (AGM) to be held virtually on September 19, 2025. Shareholders will vote on adopting the audited financial statements for the fiscal year ended March 31, 2025. Other key agenda items include the re-appointment of Dr. V. Prasada Raju as a Director and approving his remuneration as Managing Director, totaling approximately ₹5.48 Cr annually. The company also seeks approval for the appointment of M/s Makarand M. Joshi & Co. as Secretarial Auditors for five years, at ₹0.03 Cr per annum. E-voting will be open from September 15 to September 18, 2025.